Printed From BioPortfolio.com
Immunotherapy Could Offer Hope for Some Men with Aggressive Prostate Cancers
06:25 EDT 27 Sep 2018 | Lab Bulletin
Study finds that a subset of men with prostate cancer have ‘mismatch’ DNA repair defects in their tumours. These men have very aggressive disease with worse survival on currently available therapies BUT are more likely to benefit from immunotherapy. New trials beginning of checkpoint inhibitor immunotherapy in this group of patients. A group of men with especially aggressive...
Original Article: Immunotherapy Could Offer Hope for Some Men with Aggressive Prostate Cancers
